期刊文献+

M3受体通过激活MEK1/2-ERK1/2信号通路促进H9c2心肌细胞生存 被引量:2

M3 muscarinic acetylcholine receptors promote the survival of H9c2 cardiomyocytes through activating MEK1/2-ERK1/2 signaling pathway
下载PDF
导出
摘要 目的研究毒蕈碱型胆碱受体(M受体)对H9c2心肌细胞MEK1/2-ERK1/2信号通路的调控作用及其对细胞活力的影响。方法 H9c2心肌细胞用非选择性或选择性M受体拮抗药处理30 min之后,以氨甲酰胆碱刺激细胞,然后用Western Blot检测全细胞蛋白质中MEK1/2和ERK1/2磷酸化水平的变化,采用Alamar Blue法检测细胞活力。结果以氨甲酰胆碱刺激H9c2心肌细胞能显著增加MEK1/2和ERK1/2的磷酸化水平,这种活化作用可被非选择性M受体拮抗药阿托品完全阻断;M3受体选择性拮抗药DAU 5884可以阻断氨甲酰胆碱对MEK1/2-ERK1/2的激活,但M1、M2和M4受体的选择性拮抗药则没有这种阻断作用;在无血清的培养基中,氨甲酰胆碱能增加H9c2心肌细胞的生存能力,这种细胞保护作用可被阿托品和DAU 5884消除。结论在H9c2心肌细胞中,氨甲酰胆碱通过M3受体调控MEK1/2-ERK1/2信号通路,并由此促进细胞的生存。 Objective To determine the effect of muscarinic acetylcholine receptor(M-receptor) stimulation on the activation of MEK1/2-ERK1/2 signaling pathway and the cell viability in H9c2 cardiomyocytes.Methods H9c2 cardiomyocytes were treated with or without non-selective or subtype selective M-receptor antagonists,then treated with carbachol or vehicle.The cell lysates were subjected to Western Blot to determine the phosphorylation level of MEK1/2 and ERK1/2.Alarma Blue assays were employed to measure the cell viability.Results M receptor stimulation with carbachol significantly increased the phosphorylation of MEK1/2 and ERK1/2,which was abrogated by atropine pretreatment,a non-selective M-receptor antagonist,and DAU 5584,an M3-receptor selective antagonist.M1-,M2-or M4-receptor selective antagonists did not block the effect of carbachol.In an cell survival/death model in H9c2 cardiomyocytes deprived of serum growth factors,carbachol increased the cell viability,an effect blocked by atropine and DAU 5584.Conclusion M3-receptor activates MEK1/2-ERK1/2 signaling pathway and promotes the cell survival response in H9c2 cardiomyocytes.
出处 《中南药学》 CAS 2011年第3期161-165,共5页 Central South Pharmacy
关键词 毒蕈碱型胆碱受体 MEK1/2-ERK1/2信号通路 H9C2心肌细胞 细胞生存 muscarinic acetylcholine receptor MEK1/2-ERK1/2 signaling pathway H9c2 cardiomyocyte cell survival
  • 相关文献

参考文献20

  • 1Dhein S,van Koppen CJ,Brodde OE.Muscarinic receptors in the mammalian heart[J].Pharmacol Res,2001,44(3):161-182.
  • 2Wang Z,Shi H,Wang H.Functional M3 muscarinic acetylcholine receptors in mammalian hearts[J].Br J Pharmacol,2004,142(3):395-408.
  • 3Greenwood JM,Dragunow M.M3 muscarinic receptors promote cell survival through activation of the extracellular regulated kinase(ERK1/2)pathway[J].Eur J Pharmacol,2010,640(1-3):38-45.
  • 4Lin AL,Zhu B,Zhang W,et al.Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line[J].Am J Physiol Cell Physiol,2008,294(6):C1454-1464.
  • 5Granata R,De Petrini M,Trovato L,et al.Insulin-like growth factor binding protein-3 mediates serum starvation-and doxorubicin-induced apoptosis in H9c2 cardiac cells[J].J Endocrinol Invest,2003,26(12):1231-1241.
  • 6Yang B,Lin H,Xu C,et al.Choline produces cytoprotective effects against ischemic myocardial injuries:evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors[J].Cell Physiol Biochem,2005,16(4-6):163-174.
  • 7Hang PZ,Zhao J,Wang YP,et al.Reciprocal regulation between M3 muscarinic acetylcholine receptor and protein kinase C-epsilon in ventricular myocytes during myocardial ischemia in rats[J].Naunyn Schmiedebergs Arch Pharmacol,2009,380(5):443-450.
  • 8Krejci A,Tucek S.Quantitation of mRNAs for M(1)to M (5)subtypes of muscarinic receptors in rat heart and brain cortex[J].Mol Pharmacol,2002,61(6):1267-72.
  • 9Ponicke K,Heinroth-Hoffmann I,Brodde OE.Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats[J].Br J Pharmacel,2003,138(1):156-160.
  • 10Lorenz K,Schmitt JP,Vidal M,Lohse MJ.Cardiac hypertrophy:targeting Raf/MEK/ERK1/2-signaling[J].Int J Biochem Cell Biol,2009,41(12):2351-2355.

同被引文献35

  • 1Xu JX, Si M, Zhang HR, et al. Phosphoinositide Kinases Play Key Roles in Norepinephrine - and Angiotensin H - induced Increase in Phosphatidyli- nositol -4,5 - Bisphosphate and Modulation of Cardiac Function[J]. J Biol Chem,2014,21 (4) :556.
  • 2Wahher S, Awad S, Lonchyna VA, et al. NFAT transcription factor regula- tion by urocortin I1 in cardiac myocytes and heart failure[J]. Am J Physiol Heart Circ Physiol,2014,17(5) :785.
  • 3Lu ML, Wang HL, Wang J, et al. Astragaloside 1V Protects against Cardiac Hypertrophy via Inhibiting the Ca2+/CaN Signaling Pathway[J]. Planta Med,2014,80(1 ) :63 - 69.
  • 4Lin Q, Huang Y, Booth C J, et al. Activation of hypoxia - inducible factor - 2 in adipocytes results in pathological cardiac hypertrophy[J]. J Am Heart Assoc,2013,10,2(6) : 128.
  • 5Cavin S, Maric D, Diviani D, et al. A - kinase anchoring protein - Lbc promotes pro -fibrotic signaling in cardiac fibmblasts[J]. Biochim Bio- phys Acta, 2014,1 843 (2) : 335 - 345.
  • 6G6mez AM, Ruiz - Hurtado G, Benitah JP, et al. Ca2 + fluxes involvement in gene expression during cardiac hypertrophy [ J]. Curr Vasc Pharmacol, 2013,11 (4) :497 - 506.
  • 7Higashikuni Y, Tanaka K, Kato M, et al. Toll -like receptor -2 mediates adaptive cardiac hypertrophy in response to pressure overload through in- terleukin - 113 upregulation via nuclear factor KB activation[J] . J Am Heart Assoc ,2013,18,2(6) :256 - 258.
  • 8Maayah ZH, Ansari MA, E1 Gendy MA, et aL Development of cardiac hy- pertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway[J]. Arch Toxicol,2013,19(8):226 -227.
  • 9Zeng SY, Chen X, Chen SR, et al. Upregulation of Nox4 promotes an- giotensin 1I- induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression[J]. Can J Cardiol,2013,29(10) :1 310 - 1 319.
  • 10Liu S, Zhao C, Yang C, et al. Gambogic acid suppresses pressure overload cardiac hypertrophy in rats[J ]. Am J Cardiovasc Dis,2013,3 (4) :227 - 238.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部